3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Dermatologic
1
Breast
1
Conditions
Breast Neoplasms
12
Motor Activity
5
Colorectal Neoplasms
5
Neoplasms
4
Smoking Cessation
3
Endometrial Neoplasms
3
Uterine Cervical Neoplasms
2
Smoking
2
Prostatic Neoplasms
2
Papillomavirus Infections
2
Lung Neoplasms
2
Colonic Neoplasms
2
Behavior
2
Skin Cancer Prevention
1
Polycystic Ovary Syndrome
1
Patient Compliance
1
Pancreatic Neoplasms
1
Overweight
1
Ovarian Neoplasms
1
Other Cancer
1
Obesity
1
Melanoma
1
Lymphedema
1
Gastrointestinal Neoplasms
1
Colorectal Cancer Screening
1
Chronic Pain
1
Body Weight Changes
1
Body Weight
1
Anxiety Disorders
1
Interventions
Blood Specimen Collection
11
Radiosurgery
7
Sentinel Lymph Node Biopsy
5
Early Intervention, Educational
5
Surveys and Questionnaires
4
Standard of Care
4
Practice Guidelines as Topic
4
Methods
4
Indocyanine Green
4
Educational Status
4
X-Rays
3
Surgical Procedures, Operative
3
Nivolumab
3
Magnetic Resonance Spectroscopy
3
Ipilimumab
3
Immunotherapy
3
Cognitive Behavioral Therapy
3
Biopsy
3
pembrolizumab
2
montanide ISA 51
2
aldesleukin
2
Tomography, X-Ray Computed
2
Tomography, Emission-Computed
2
Specimen Handling
2
Radiotherapy
2
Radiation
2
Positron-Emission Tomography
2
Palliative Care
2
Observation
2
Interviews as Topic
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
Melanoma
×
Motivational Interviewing
×
Clear all
NCT04899492
2024-11-07
RESPIRE
Institut Cancerologie de l'Ouest
Phase NA
Terminated
22 enrolled